Chemotherapy Regime Therapy Naming Conventions

This Editorial Guide is used for Education Purposes Only. It is used in the Authoring Courses and Certifications. It is based on the January 2026 Editorial Guide.

Chemotherapy regimens, which are internationally recognized and implemented, are acceptable content and may be added to the (regime/therapy) hierarchy as subtypes of 716872004 | Antineoplastic chemotherapy regimen (regime/therapy)|.

Trade names, which are indicated by an acronym, e.g. ABVD chemotherapy regimen, where A represents trade name Adriamycin®, should not be spelled out but may be referenced in the acronym used to describe the regimen.

Generic drug names are not capitalized; they are lower case. When creating descriptions for generic drug names, the substance described should match the description from the Substance hierarchy.

Examples,

ABVD chemotherapy regimen. A represents the trade name Adriamycin® (INN = doxorubicin):

• FSN: Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy regimen (regime/therapy)

  • PT: ABVD chemotherapy regimen

  • Synonym: Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy regimen

  • Synonym: ABVD chemotherapy protocol

R-CHOP chemotherapy regimen.H represents the non-INN generic name hydroxydaunomycin (INN = doxorubicin) and O represents the trade name Oncovin® (INN = vincristine):

• FSN: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy)

  • PT: R-CHOP chemotherapy regimen

  • Synonym: Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen

  • Synonym: R-CHOP chemotherapy protocol

Provide Feedback